The Academy by Psych Scene is a transformative platform tailored for psychiatry professionals who seek to excel in their field. Our meticulously curated content, crafted by psychiatry experts and elite learning designers, focuses on enhancing your practical knowledge and clinical expertise at an exceptional value.
Our dynamic courses will give you cutting-edge skills and insights to keep you at the forefront of the rapidly evolving psychiatry landscape. Each course also contributes towards your Psychiatry CME and CPD points, supporting your continuous professional development.
Our mission is to empower health professionals with advanced psychiatric knowledge, fostering transformative change in mental health care.
🎓 150+ hours of cutting-edge, interactive courses
🎓 Video interviews with experts
🎓 Free PDF downloads
🎓 Collaborations platform - ask and share
🎓 Advanced AI for efficient learning
🎓 Earn Psychiatry CME credits / CPD points
🎓 FREE CPD portfolio tracker
The Academy by Psych Scene
Schizophrenia treatment isn’t just about dopamine.
Most antipsychotics reduce D2 signalling, yet negative and cognitive symptoms remain inadequately addressed.
Here’s how that gap has put muscarinic signalling in focus, and what the existing evidence says.
For more evidence-based psychiatry insights like this, join the Psych Scene newsletter.
We share clinical frameworks, research updates, diagnostic explainers, and practical resources designed to support mental health professionals in practice.
Link in the comments below.
4 days ago | [YT] | 17
View 1 reply
The Academy by Psych Scene
To learn more about sleep expectation mismatch and how arousal states shape sleep treatment, click the link in the comments below and check out the full course inside The Academy.
1 week ago | [YT] | 3
View 1 reply
The Academy by Psych Scene
Autoimmune disease can look entirely psychiatric at onset.
Early presentations often mimic primary psychosis, mania or catatonia.
Here are 7 immune-driven brain changes every clinician should recognise👇🧵
If these 7 patterns help sharpen your diagnostic radar, they represent only a fraction of what we cover in our Neuroimmunology modules.
Join The Academy by Psych Scene for 150+ hours of CPD-accredited training translating neuroimmune mechanisms into practical assessment and management, click the link in the comments below to learn more.
1 week ago | [YT] | 15
View 1 reply
The Academy by Psych Scene
When we say a treatment has a target, what exactly are we targeting?
A receptor, a neural circuit, a symptom, functional recovery, or a goal that matters to the patient?
For clinicians, the challenge is not simply to identify the target, but to connect mechanisms with clinical change, and clinical change with meaningful recovery.
Led by Dr Sanil Rege, join us at The Academy for Emerging Treatment Targets In Psychiatry: Translating New Mechanisms into Clinical Practice.
This live online webinar explores emerging targets and therapeutic advances across molecular, brain–body, circuit, phenomenological, functional and relational levels, and how they connect with meaningful recovery.
After this webinar, participants will be able to:
- Distinguish therapeutic targets from markers of change and clinically meaningful outcomes.
- Map targets across molecular, brain–body, circuit, phenomenological, functional and relational levels.
- Examine novel pathways, rapid-acting treatments, neuromodulation and precision psychiatry.
- Apply a domain-based framework to identify individualised, trackable targets across perception, activity, cognition, emotion and sleep.
Event details:
📅 Date: 9 September 2026
🕖 Time: 6–8 PM AEST
📍 Format: Live Online Webinar via Zoom
🎟️ Access: Free for Academy members / $89 AUD for non-members
Upon completion, all participants will receive:
✔️ CPD Certificate
✔️ 2 CPD hours:
✔️ Q&A
✔️ 30-Day Replay Access
Psychiatry is moving towards a richer hierarchy of treatment targets.
But greater biological precision is only part of the picture.
Molecules and circuits matter.
So do symptoms, function, relationships, and recovery.
The challenge is understanding how these levels connect to meaningful clinical change and recovery.
Click the link in the comments below and reserve your spot now.
1 week ago | [YT] | 7
View 1 reply
The Academy by Psych Scene
Here’s what a clinician is saying about the course: Dialectical Behaviour Therapy - A Practical Guide for Clinicians.
This course explores key DBT principles, including mindfulness, distress tolerance, emotion regulation, and interpersonal effectiveness.
Earn 7 CPD hours and recognise the principles and benefits of DBT in a clinical setting through the link in the comment section.
2 weeks ago | [YT] | 4
View 1 reply
The Academy by Psych Scene
A smoking cessation plan has to manage more than just nicotine removal.
It also has to manage what happens when nicotine is absent.
This is what varenicline is ‘designed’ to help with.
For more evidence-based psychiatry insights like this, join the Psych Scene newsletter.
We share clinical frameworks, research updates, diagnostic explainers, and practical resources designed to support mental health professionals in practice.
Link in the comments below.
2 weeks ago | [YT] | 10
View 1 reply
The Academy by Psych Scene
Psychedelic-assisted psychotherapy is often discussed as a breakthrough, a controversy, or a future direction in mental health care.
But for clinicians, the real challenge is understanding where existing evidence ends, where clinical judgement begins, and what safeguards must first be in place before clinical use.
Led by Dr Jonathan Laugharne, our Psychedelic-Assisted Psychotherapy course provides clinicians with a clinically grounded introduction to psychedelic-assisted psychotherapy.
This on-demand course examines MDMA and psilocybin, current evidence, Australian regulation, patient selection, clinical governance, and preparation, dosing, and integration.
In this course, you’ll learn how to:
- Explain core principles of psychedelic-assisted psychotherapy
- Compare MDMA and psilocybin mechanisms
- Review evidence for MDMA-assisted psychotherapy in PTSD and psilocybin-assisted therapy in depression
- Outline Australian regulation and patient-selection considerations
- Describe preparation, dosing, and integration phases, including the experiential dimensions of treatment
Accreditation:
✅ 1.5 CPD hours
✅ Self-accreditable with RANZCP
✅ Self-accreditable with RACGP
✅ Certificate of Completion
Start learning today. Link in the comments below.
3 weeks ago | [YT] | 6
View 1 reply
The Academy by Psych Scene
Brain scans can show what “lights up” when a symptom is experienced.
But they cannot tell whether that activity is driving, regulating, or merely responding to the symptom.
Optogenetics can.
It tests symptom causality at the level of cells, projections, and circuits.
To keep up with emerging neuroscience that may shape the future of psychiatric diagnosis and treatment, join the Psych Scene newsletter.
We share clinical frameworks, research updates, diagnostic explainers, and practical resources designed to support mental health professionals in practice.
Link in the comments below.
3 weeks ago | [YT] | 17
View 1 reply
The Academy by Psych Scene
Depression is not ‘just a mood problem’.
Patients may improve emotionally but still struggle with attention, memory, mental clarity, anhedonia, and functional recovery.
That is where vortioxetine’s mechanism becomes clinically relevant.
For more evidence-based psychiatry insights like this, join the Psych Scene newsletter.
We share clinical frameworks, research updates, diagnostic explainers, and practical resources designed to support mental health professionals in practice.
Link in the comments below.
3 weeks ago | [YT] | 16
View 1 reply
The Academy by Psych Scene
To learn more about atomoxetine’s mechanism of action and its role in ADHD treatment, click the link below and check out the full course inside The Academy:
3 weeks ago | [YT] | 12
View 0 replies
Load more